Heartland Advisors Inc. Purchases New Position in Humana Inc. $HUM

Heartland Advisors Inc. acquired a new position in Humana Inc. (NYSE:HUMFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 23,888 shares of the insurance provider’s stock, valued at approximately $6,118,000.

Other hedge funds have also bought and sold shares of the company. Revolve Wealth Partners LLC purchased a new position in shares of Humana in the fourth quarter valued at $202,000. Woodline Partners LP lifted its holdings in Humana by 460.0% during the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares in the last quarter. Sivia Capital Partners LLC boosted its stake in Humana by 53.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after purchasing an additional 452 shares during the period. Cresset Asset Management LLC grew its holdings in Humana by 10.3% during the 2nd quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after buying an additional 222 shares in the last quarter. Finally, WINTON GROUP Ltd grew its holdings in Humana by 58.5% during the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after buying an additional 879 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on HUM shares. Oppenheimer raised shares of Humana from an “outperform” rating to an “outperform” rating in a report on Wednesday, May 20th. Needham & Company LLC assumed coverage on shares of Humana in a research note on Wednesday, May 20th. They set a “buy” rating for the company. Deutsche Bank Aktiengesellschaft cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, May 20th. Jefferies Financial Group raised shares of Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $425.00 price target on shares of Humana in a research report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, fourteen have given a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $286.13.

Get Our Latest Research Report on HUM

Humana Stock Up 0.7%

Shares of NYSE HUM opened at $365.89 on Thursday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The business has a 50-day moving average of $259.94 and a 200-day moving average of $235.20. The firm has a market capitalization of $43.93 billion, a price-to-earnings ratio of 39.13, a PEG ratio of 2.08 and a beta of 0.76. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $369.34.

Humana (NYSE:HUMGet Free Report) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. During the same period in the previous year, the business posted $11.58 earnings per share. Humana’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts expect that Humana Inc. will post 9 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s payout ratio is currently 37.86%.

About Humana

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Further Reading

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.